CTM-PNK

About CytoMed Therapeutics

CytoMed Therapeutics is a clinical-stage biotech focused on translating innovative allogeneic cell therapies into treatments for a broad spectrum of cancers. Its mission is to overcome the manufacturing complexity, cost, and delay associated with autologous cell therapies by leveraging donor-derived gamma-delta T cells and NK cells. The company has established a dual-platform strategy, combining its proprietary cell expansion techniques with CAR engineering, and is progressing multiple candidates towards clinical validation. As a public entity, CytoMed is positioned within Singapore's strong biomedical ecosystem to advance its next-generation immunotherapy pipeline.

Therapeutic Areas

Other Hematological Cancers Drugs